Serial Number 90403343
Registration 6933007
700

Registration Progress

Application Filed
Dec 22, 2020
Under Examination
Approved for Publication
Oct 11, 2022
Published for Opposition
Oct 11, 2022
Registered
Dec 27, 2022

Basic Information

Serial Number
90403343
Registration Number
6933007
Filing Date
December 22, 2020
Registration Date
December 27, 2022
Published for Opposition
October 11, 2022
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 27, 2022
Registration
Registered
Classes
005

Rights Holder

Kissei Pharmaceutical Co., Ltd.

03
Address
19-48, Yoshino, Matsumoto-shi
Nagano 399-8710
JP

Ownership History

Kissei Pharmaceutical Co., Ltd.

Original Applicant
03
Nagano JP

Kissei Pharmaceutical Co., Ltd.

Owner at Publication
03
Nagano JP

Kissei Pharmaceutical Co., Ltd.

Original Registrant
03
Nagano JP

Legal Representation

Attorney
John Mueller
USPTO Deadlines 2 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-27)
R.PRA Dec 27, 2028 1269 days Critical No
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2022-12-27)
R.PRA Dec 27, 2032 2730 days Critical No
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-27) on December 27, 2028 (1269 days)

Application History

35 events
Date Code Type Description
Mar 7, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 7, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 7, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 7, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 7, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 7, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 7, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 27, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 27, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 11, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 11, 2022 PUBO A PUBLISHED FOR OPPOSITION
Sep 21, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2022 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Sep 2, 2022 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Aug 26, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 13, 2022 GNRT O NON-FINAL ACTION E-MAILED
Apr 13, 2022 CNRT R NON-FINAL ACTION WRITTEN
Sep 16, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 16, 2021 GNSL S LETTER OF SUSPENSION E-MAILED
Sep 16, 2021 CNSL R SUSPENSION LETTER WRITTEN
Sep 3, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2021 ALIE A ASSIGNED TO LIE
Aug 30, 2021 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 17, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 17, 2021 GNSL F LETTER OF SUSPENSION E-MAILED
Jun 17, 2021 CNSL R SUSPENSION LETTER WRITTEN
Jun 17, 2021 DOCK D ASSIGNED TO EXAMINER
Mar 10, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 9, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 25, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment and prevention of endometriosis, uterine fibroids and other disorders of the reproductive system, of hormonally dependent conditions, and of inflammatory and immune system disorders

Active Deadlines

Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-27)
Due: Dec 27, 2028
Grace Period Until: Jun 27, 2029
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2022-12-27)
Due: Dec 27, 2032
Grace Period Until: Jun 27, 2033

Additional Information

Design Mark
The mark consists of a circle with a light-shaded center element dividing the circle into three ovals. The top oval is colored purple, the lower right oval is colored royal blue and the lower left oval is colored navy blue.
Color Claim
The color(s) purple, royal blue and navy blue is/are claimed as a feature of the mark.

Classification

International Classes
005